Found 164 matching trials
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy PHASE3 This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy PHASE2 Head and neck cancer is the malignant tumor with the highest morbidity and ...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients PHASE3 This is a multicenter, randomized controlled, phase III clinical trial. The...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma PHASE2 Neoadjuvant chemotherapy plus toripalimab in patients with locoregionally a...
Show More Status
Active Not Recruiting
Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma PHASE2 This phase II randomized trial compares the efficacy and safety of Toripali...
Show More Location
Dongguan People's Hospital
Learn More & Join Trial
Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects PHASE2 This is a pre-surgical study involving subjects with local advanced bladder...
Show More Location
Zhujiang Hospital
Learn More & Join Trial
GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma PHASE2 Nasopharyngeal carcinoma (NPC) has a low incidence rate in children, accoun...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Neoadjuvant Chemoradiotherapy Combined With PD-1 Antibody in Locally Advanced Esophageal Cancer PHASE2 This study will evaluate the safety and feasibility of preoperative immune ...
Show More Location
Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
Learn More & Join Trial
Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma PHASE2 This study is designed as Phase II/III. Phase II is aimed to evaluate safet...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor PHASE2 This is a phase II, single-arm, open-label study to evaluate the efficacy a...
Show More Location
Shanghai Pulmonary Hospital
Learn More & Join Trial